Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000258558 is a long non-coding RNA (lncRNA) transcript located antisense to the SCFD1 gene. As an antisense RNA, it may influence SCFD1 gene expression via transcriptional or post-transcriptional mechanisms, though no specific function has been experimentally confirmed for this transcript. Generally, antisense lncRNAs can regulate their paired protein-coding gene partners by multiple mechanisms—including modulating alternative splicing, stability, and epigenetic states, but many such transcripts, including ENSG00000258558, remain largely uncharacterized and may lack evolutionary conservation[2][3]. Their regulatory potential marks them as interesting loci for research into gene expression and disease, but they are not considered direct therapeutic targets like receptors or enzymes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to SCFD1 (ENSG00000258558).